This Award Notice opportunity from Department Of Defense was posted on August 25, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
MELOXICAM TABLETS
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Defense Logistics Agency awarded contract SPE2DP22F4391 to DMS Pharmaceutical Group Inc for the procurement of Meloxicam Tablets under delivery order SPE2DX15D9383. This action was categorized under NAICS code 325412 and was part of a larger commercial items contract framework with a total award value of 4,999,999.00 dollars. Subsequent to the initial award, modification P00001 was issued by DLA Troop Support to implement a Termination for the Government's Convenience. This modification resulted in the total cancellation of the line item for Meloxicam Tablets at no cost to the government, effectively reducing the specific contract value from 6.02 dollars to 0.00 dollars.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
